Disruption of estrogen signaling does not prevent progesterone action in the estrogen receptor alpha knockout mouse uterus.
Estrogen is known to increase progesterone receptor (PR) levels in the wild-type mouse uterus, and this estrogen induction was thought to be important for progesterone action through the PR. The estrogen receptor alpha knockout (ERKO) mouse uterus was observed to express PR mRNA that cannot be induced by estrogen. Progesterone action was characterized to determine whether it was diminished in ERKO mice. The PR protein is present in the ERKO uterus at 60% of the level measured in a wild-type uterus. The PR-A and PR-B isoforms are both detected on Western blot, and the ratio of isoforms is the same in both genotypes. Although the level of PR is reduced in the ERKO uterus, the receptor level is sufficient to induce genomic responses, since both calcitonin and amphiregulin mRNAs were increased after progesterone treatment. Finally, the ERKO uterus can be induced to undergo a progesterone-dependent decidual response. Surprisingly, the decidual response is estrogen independent in the ERKO, although it remains estrogen dependent in a wild type. These results indicate that estrogen receptor alpha modulation of PR levels is not necessary for expression of the PR or genomic and physiologic responses to progesterone in the ERKO uterus.
Curtis
S W
SW
Receptor Biology Section, P.O. Box 12233, Research Triangle Park, NC 27709, USA.
Clark
J
J
Myers
P
P
Korach
K S
KS
D066258:Amphiregulin; D000818:Animals; D002116:Calcitonin / Q000235:genetics; D066255:EGF Family of Proteins; D004958:Estradiol / Q000494:pharmacology* / Q000502:physiology; D047628:Estrogen Receptor alpha; D004971:Estrus; D005260:Female; D005786:Gene Expression Regulation / Q000187:drug effects / Q000502:physiology*; D006023:Glycoproteins / Q000235:genetics; D006133:Growth Substances / Q000235:genetics; D036341:Intercellular Signaling Peptides and Proteins; D051379:Mice; D018345:Mice, Knockout; D010052:Ovariectomy; D011374:Progesterone / Q000494:pharmacology* / Q000502:physiology; D011397:Promegestone / Q000493:pharmacokinetics; D012333:RNA, Messenger / Q000235:genetics; D011869:Radioligand Assay; D011960:Receptors, Estrogen / Q000172:deficiency / Q000235:genetics / Q000502:physiology*; D011980:Receptors, Progesterone / Q000235:genetics*; D012741:Sexual Maturation; D015398:Signal Transduction; D014158:Transcription, Genetic / Q000187:drug effects; D014316:Tritium; D014599:Uterus / Q000502:physiology*
D066258:Amphiregulin; C587849:Areg protein, mouse; D066255:EGF Family of Proteins; D047628:Estrogen Receptor alpha; D006023:Glycoproteins; D006133:Growth Substances; D036341:Intercellular Signaling Peptides and Proteins; D012333:RNA, Messenger; D011960:Receptors, Estrogen; D011980:Receptors, Progesterone; C101118:progesterone receptor A; C097314:progesterone receptor B; D014316:Tritium; D011374:Progesterone; D004958:Estradiol; D002116:Calcitonin; D011397:Promegestone